Literature DB >> 19966185

Signal transducer and activator of transcription (STAT)-5A and STAT5B differentially regulate human mammary carcinoma cell behavior.

Jian-Zhong Tang1, Ze-Hua Zuo, Xiang-Jun Kong, Michael Steiner, Zhinan Yin, Jo K Perry, Tao Zhu, Dong-Xu Liu, Peter E Lobie.   

Abstract

Increased activation of signal transducer and activator of transcription (STAT)-5 has been reported in various malignancies including mammary carcinoma. However, it is only recently that potentially distinct roles of STAT5A and STAT5B in neoplasia have begun to emerge. Herein we systematically delineate the functions of STAT5A and STAT5B in human mammary carcinoma cell lines MCF-7 and T47D. Forced expression of constitutively active (CA) STAT5A enhanced both survival and anchorage-independent growth of human mammary carcinoma cells but concordantly suppressed cell motility as revealed in colony scattering, cell migration, and invasion assays. In contrast, forced expression of CA STAT5B exhibited lower potency than CA STAT5A in enhancing survival and anchorage-independent growth of mammary carcinoma cells and exerted no effects on cell motility. Differential expression of genes that regulate cellular survival and motility was concomitantly observed on forced expression of CA STAT5A or CA STAT5B. Small interfering RNA-mediated depletion of STAT5A significantly impaired anchorage-independent growth of human mammary carcinoma cells, whereas a smaller reduction was observed upon small interfering RNA-mediated depletion of STAT5B. Depletion of endogenous STAT5A also significantly enhanced cell motility, whereas depletion of endogenous STAT5B exhibited no effect. Xenograft studies provided data concordant with the in vitro effects of the two STAT5 isoforms. We therefore demonstrate that STAT5A and STAT5B differentially regulate behavior of human mammary carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19966185     DOI: 10.1210/en.2009-0651

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  24 in total

1.  Autocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast Cancer.

Authors:  Weijie Zhang; Pengxu Qian; Xiao Zhang; Min Zhang; Hong Wang; Mingming Wu; Xiangjun Kong; Sheng Tan; Keshuo Ding; Jo K Perry; Zhengsheng Wu; Yuan Cao; Peter E Lobie; Tao Zhu
Journal:  J Biol Chem       Date:  2015-04-14       Impact factor: 5.157

2.  Characterization of kiss2 and kissr2 genes and the regulation of kisspeptin on the HPG axis in Cynoglossus semilaevis.

Authors:  Huayu Song; Mengxun Wang; Zhongkai Wang; Jinxiang Liu; Jie Qi; Quanqi Zhang
Journal:  Fish Physiol Biochem       Date:  2016-12-24       Impact factor: 2.794

3.  Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinoma.

Authors:  Nagarajan Kannan; Jian Kang; Xiangjun Kong; Jianzhong Tang; Jo K Perry; Kumarasamypet M Mohankumar; Lance D Miller; Edison T Liu; Hichem C Mertani; Tao Zhu; Prudence M Grandison; Dong-Xu Liu; Peter E Lobie
Journal:  Neoplasia       Date:  2010-12       Impact factor: 5.715

4.  Role of ERalpha in the differential response of Stat5a loss in susceptibility to mammary preneoplasia and DMBA-induced carcinogenesis.

Authors:  Anne M Miermont; Angela R Parrish; Priscilla A Furth
Journal:  Carcinogenesis       Date:  2010-02-24       Impact factor: 4.944

5.  Histone H1 and Chromosomal Protein HMGN2 Regulate Prolactin-induced STAT5 Transcription Factor Recruitment and Function in Breast Cancer Cells.

Authors:  Suzanne M Schauwecker; J Julie Kim; Jonathan D Licht; Charles V Clevenger
Journal:  J Biol Chem       Date:  2016-12-29       Impact factor: 5.157

6.  STAT5A-mediated SOCS2 expression regulates Jak2 and STAT3 activity following c-Src inhibition in head and neck squamous carcinoma.

Authors:  Banibrata Sen; Shaohua Peng; Denise M Woods; Ignacio Wistuba; Diana Bell; Adel K El-Naggar; Stephen Y Lai; Faye M Johnson
Journal:  Clin Cancer Res       Date:  2011-11-16       Impact factor: 12.531

7.  Janus kinase 2 is required for the initiation but not maintenance of prolactin-induced mammary cancer.

Authors:  K Sakamoto; A A Triplett; L A Schuler; K-U Wagner
Journal:  Oncogene       Date:  2010-07-19       Impact factor: 9.867

8.  STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma.

Authors:  Katharina L Kopp; Ulrik Ralfkiaer; Lise Mette R Gjerdrum; Rikke Helvad; Ida H Pedersen; Thomas Litman; Lars Jønson; Peter H Hagedorn; Thorbjørn Krejsgaard; Robert Gniadecki; Charlotte M Bonefeld; Lone Skov; Carsten Geisler; Mariusz A Wasik; Elisabeth Ralfkiaer; Niels Ødum; Anders Woetmann
Journal:  Cell Cycle       Date:  2013-05-15       Impact factor: 4.534

9.  Prolactin activates ERα in the absence of ligand in female mammary development and carcinogenesis in vivo.

Authors:  Kathleen A O'Leary; Fatou Jallow; Debra E Rugowski; Ruth Sullivan; Kerstin W Sinkevicius; Geoffrey L Greene; Linda A Schuler
Journal:  Endocrinology       Date:  2013-09-24       Impact factor: 4.736

Review 10.  Mammary gland growth factors: roles in normal development and in cancer.

Authors:  Nancy E Hynes; Christine J Watson
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-16       Impact factor: 10.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.